Our investigational Controlled Metabolic Accelerator increases metabolism and reduces body fat, which is pivotal to the development of #HFpEF. The rationale and design of our Phase 2a clinical trial in HFpEF are now published in European Society of Cardiology. Learn more: bit.ly/3VZWcBW.
About us
Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/
- Website
-
https://www.rivuspharma.com/
External link for Rivus Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
Employees at Rivus Pharmaceuticals
Updates
-
Obesity and other metabolic diseases are major risk factors for #MASH. This Global Fatty Liver Day, we're joining the community in raising awareness about this progressive liver disease and the urgent need to expand treatment options for patients. Learn more about our approach to treating metabolic diseases: rivuspharma.com
-
-
Our CEO, Dr. Jayson Dallas, is sharing how we're shaking up the current treatment paradigm for metabolic diseases underserved by existing therapeutic options. Read more from FirstWord Pharma about our next-generation approach and its potential to help overcome the limitations of existing treatments by increasing metabolic rate: https://bit.ly/44LZRX1
-
🚨 Attention Job Seekers! 🚨 It has come to our attention that there are job scammers impersonating Rivus, and our employees. Please be vigilant and exercise caution when interacting with potential employers. Here are a few important reminders: - We always require an in person interview - We NEVER conduct interviews via Teams - We NEVER communicate via text message or other third-party apps - We always communicate using our company email address, we NEVER use gmail or other personalized email addresses - We NEVER provide a check to purchase home office equipment - Be wary of unsolicited job offers or requests for personal information Please be vigilant before you start communicating with any "recruiters" that contact you claiming they have a remote position that you are a fit for. Always check the company's website and LinkedIn page to verify that the job post is legitimate and the person you are communicating with actually works for Rivus.
-
We're #hiring a new Head, Quality - GCP/GMP/GLP in Charlottesville, Virginia. Apply today or share this post with your network.
-
We're developing a new class of investigational medicines that target energy consumption instead of energy intake, resulting in fat-specific weight-loss. Our CEO, Dr. Jayson Dallas, shares with PharmaVoice how our unique therapeutic approach stands out amidst a crowded landscape and how we are aiming to go beyond obesity to treat cardiometabolic diseases. Read more: https://bit.ly/3IUnp1T
-
We're #hiring a new Senior Director / Vice President, Regulatory Affairs - Obesity and Associated Metabolic Diseases in San Francisco Bay Area. Apply today or share this post with your network.
-
We're #hiring a new Senior Director, Quality- Small Molecule Therapeutics in Charlottesville, Virginia. Apply today or share this post with your network.
-
We're #hiring a new Senior Director, CMC Development- Small Molecule Therapeutics in Charlottesville, Virginia. Apply today or share this post with your network.